
Cancel anytime
- Chart
- Upturn Summary
- Highlights
Upturn AI SWOT - About
Innovator IBD® 50 ETF (FFTY)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/24/2025: FFTY (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type ETF | Historic Profit 36.69% | Avg. Invested days 59 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() | Upturn Advisory Performance | ETF Returns Performance |
Key Highlights
Volume (30-day avg) - | Beta 1.38 | 52 Weeks Range 22.75 - 34.26 | Updated Date 06/29/2025 |
52 Weeks Range 22.75 - 34.26 | Updated Date 06/29/2025 |
Upturn AI SWOT
Innovator IBD® 50 ETF
ETF Overview
Overview
The Innovator IBDu00ae 50 ETF (FFTY) aims to track the performance of the IBD 50 Index, which comprises 50 growth stocks identified by Investor's Business Daily (IBD) based on earnings and price performance.
Reputation and Reliability
Innovator Capital Management is known for its defined outcome ETFs and innovative investment strategies.
Management Expertise
Innovator's management team has experience in developing and managing various ETF products.
Investment Objective
Goal
To track the performance, before fees and expenses, of the IBDu00ae 50 Index.
Investment Approach and Strategy
Strategy: The ETF aims to replicate the IBD 50 Index, which uses a proprietary methodology to identify leading growth stocks.
Composition The ETF primarily holds common stocks of the 50 companies in the IBD 50 Index.
Market Position
Market Share: FFTY has a small market share compared to broader growth ETFs.
Total Net Assets (AUM): 195492845
Competitors
Key Competitors
- IWF
- VUG
- QQQ
Competitive Landscape
The competitive landscape is dominated by large-cap growth ETFs. FFTY differentiates itself with the IBD 50 Index methodology, offering potential outperformance but also increased volatility. Its smaller size results in lower liquidity compared to larger competitors.
Financial Performance
Historical Performance: Historical performance varies depending on the specific time period and market conditions.
Benchmark Comparison: The ETF's performance should be compared to the IBD 50 Index to gauge its tracking effectiveness.
Expense Ratio: 0.8
Liquidity
Average Trading Volume
FFTY's average trading volume is moderate, reflecting its niche focus and smaller size.
Bid-Ask Spread
The bid-ask spread can fluctuate depending on market conditions and trading volume.
Market Dynamics
Market Environment Factors
Economic growth, interest rates, and investor sentiment towards growth stocks influence FFTY's performance.
Growth Trajectory
FFTY's growth is tied to the performance of the IBD 50 Index and investor interest in growth strategies. The holdings may be reconstituted on a regular basis based on the IBD methodology.
Moat and Competitive Advantages
Competitive Edge
FFTY's competitive edge lies in its unique IBD 50 Index methodology, which focuses on identifying leading growth stocks based on earnings and price performance. This disciplined approach aims to select companies with strong growth potential. The ETF's strategy differentiates it from broad-based growth ETFs that may include companies with less compelling growth characteristics. However, this focused approach may also lead to higher volatility.
Risk Analysis
Volatility
FFTY exhibits moderate volatility, reflecting the growth-oriented nature of its holdings.
Market Risk
The ETF is subject to market risk, including fluctuations in stock prices and broader economic downturns.
Investor Profile
Ideal Investor Profile
FFTY is suitable for investors seeking exposure to growth stocks identified by the IBD methodology and willing to accept moderate volatility.
Market Risk
FFTY may be suitable for investors with a long-term investment horizon who are comfortable with active management and growth-oriented strategies.
Summary
Innovator IBDu00ae 50 ETF (FFTY) is a growth-focused ETF that tracks the IBD 50 Index. Its unique selection methodology targets leading growth stocks, potentially offering outperformance but also higher volatility. The ETF is suitable for investors seeking a differentiated growth strategy, however it has a higher expense ratio than larger, broader based growth ETFs. Investors should assess their risk tolerance and investment goals before investing.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Innovator Capital Management
- Investor's Business Daily
- ETF.com
- Morningstar
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered investment advice. Past performance is not indicative of future results. Investors should consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Innovator IBD® 50 ETF
Exchange NYSE ARCA | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website | ||
The fund will normally invest at least 80% of its net assets (including investment borrowings) in securities that comprise the index. The IBD® 50 Index is a weekly, rules-based, computer-generated stock index compiled and published by Investor's Business Daily® (IBD or the index provider) that seeks to identify the current top 50 growth stocks.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

